Gilead Subpoenaed By California Insurance Regulators Over Its ‘Marketing Activities’
In October 2017, the California insurance department and the Alameda County, Calif., district attorney’s office sent a subpoena to Gilead requesting documents about the company's “marketing activities, reimbursement support offerings, clinical and education programs, and interactions with specialty pharmacies.”
San Francisco Chronicle:
Federal, State Officials Probe Gilead’s Drug Marketing Practices
California insurance regulators and Alameda County prosecutors have subpoenaed Gilead Sciences for information regarding the Foster City drugmaker’s marketing practices and other services. The subpoenas, issued in October by the California Department of Insurance and the Alameda County district attorney’s office, were disclosed in a filing with the U.S. Securities and Exchange Commission in February. (Ho, 9/21)
The Wall Street Journal:
U.S. Probes Drugmakers Over Free Services
Drug companies say the services, such as nurses and reimbursement assistance, help doctors and patients. But the practices, which have become more prevalent as drugmakers have introduced more complex and expensive drugs, are drawing scrutiny over whether they serve an illegal commercial purpose: inducing sales. (Loftus, 9/21)